期刊文献+

促红细胞生成素对缺血/再灌注心室肌细胞收缩功能和钙瞬变的影响 被引量:3

Effects of erythropoietin on contraction and calcium transient in ischemia/reperfused cardiomyocytes
下载PDF
导出
摘要 目的:探讨人重组促红细胞生成素(rHuEPO)对大鼠缺血/再灌注(I/R)心肌细胞的保护作用.方法:常规酶解法获得成年大鼠心室肌细胞,用氰化钠/乳酸钠灌注造成细胞化学缺氧以模拟缺血.缺血15 m in后以台氏液或台氏液加rHuEPO复氧模拟再灌注,用可视化动缘探测系统同步检测rHuEPO对单个I/R心室肌细胞收缩力和钙瞬变的影响.结果:发现rHuEPO使再灌注后心室肌细胞肌小节最大收缩幅度、最大缩短速率、最大复长速率以及Ca2+荧光比率增大,使Ca2+达峰值时程、舒张期Ca2+减少50%时程减少(P<0.05,n=10,来自8个心脏).结论:rHuEPO可促进I/R心室肌细胞收缩及钙瞬变的恢复而发挥其保护作用. AIM: To determine the protective effect of recombinant human erythropoietin ( rHuEPO ) on ischemia/reperfused cardiomyocytes. METHODS: Ventricular myocytes were enzymatically isolated from adult SD rats. Chemical anoxic solution including sodium cyamide/sodium lactate was used to simulate myocardial ischemia. After 15 min of ischemia, myocytes were reperfused with Tyrode's solution with or without rHuEPO for 30 min. Contribution of rHuEPO to systolic/diastolic function and intraceUular calcium transient in isolated I/R ventricular myocytes was assessed by Video-based motion edge-detection system. RESULTS: Reperfusion with rHuEPO increased peak twitch amplitude, maximal velocity of shortening, maximal velocity of relengthening of myocytes shorterning and fluorescence ratio Ca^2+, and decreased time to peak Ca^2+, time to 50% diastolic Ca^2+ compared with those in cells reperfused with vehicle (n = 10 myocytes from 8 hearts, P 〈 0.05 ). CONCLUSION : Treatment with rHuEPO during reperfusion facilitates the recovery of systolic/diastohc function and calcium transient in simulated I/R cardiomyocytes.
出处 《第四军医大学学报》 北大核心 2008年第7期616-618,共3页 Journal of the Fourth Military Medical University
关键词 重组促红细胞生成素 缺血 再灌注损伤 心肌细胞 收缩功能 钙瞬变 recombinant erythropoietin ischemia reperfusioninjury cardiomyocyte contraction calcium transient
  • 相关文献

参考文献3

二级参考文献23

  • 1Lappin TR.EPO's alter ego:erythropoietin has multiple actions[J].Stem Cell,2002,20(16):485-92.
  • 2Chikuma M,Masuda S,Kobayashi T,et al.Tissue-specific regulation of erythropoietin production in the murine kidney,brain,and uterus[J].Am J Physiol Endocrinol Metab,2000,279:1242-1248.
  • 3Masuda S,Nagao M,Sasaki R.Erythropoietic,neurotrophic,and angiogenic functions of erythropoietin and regulation of erythropoietin production[J].International journal of hematology,1999,70:1-6.
  • 4Fandrey J,Freds S,Ehleben W,et al.Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species[J].J Kidney Int,1997,51(2):492-496.
  • 5Cai Z,Dominador J,Wei G,et al.Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury[J].Circulation,2003,108(1):79-85.
  • 6Jaquet K,Krause K,Tawakol-Khodai M,et al.Erythropoietin and VEGF exhibit equal angiogenic potential[J].Microvasc Res,2002,64(2):326-333.
  • 7Cerami A,Brines ML,Ghezzi P,et al.Effects of epoetin alfa on the central nervous system[J].Semin Oncol,2001,28(2):66-70.
  • 8Digicaylioglu M,Lipton SA.Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades[J].Nature,2001,412:641-647.
  • 9Joneja B,Wojchowski DM.Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor Box-1 domain[J].J Biol Chem,1997,272:11176-11184.
  • 10Zhuang H,Niu Z,He TC,et al.Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negativeforms of Jak2[J].J Biol Chem,1995,270:14500-14504.

共引文献24

同被引文献40

  • 1叶和杨,张小玲,周莉,汪秀荣,肖汉跃,何蔚,曾靖.大豆异黄酮对大鼠心肌缺血再灌注损伤的保护作用[J].中药药理与临床,2005,21(5):21-22. 被引量:10
  • 2Cai Z,SemenzaGL.Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury.Circulation,2004,109(17):2050-2053.
  • 3Fisher JW.Erythropoietin:physiology and pharmacology update.Exp Biol Med (Maywood),2003,228(1):1-14.
  • 4Juul SE,Yachnis AT,Christensen RD.Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus.Early Hum Dev,1998,52(3):235-249.
  • 5Van der Meer P,Lipsic E,Henning RH,et al.Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury.Eur J Heart Fail,2004,6(7):853-859.
  • 6Lipsic E,van der Meer P,Henning RH,et al.Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.J Cardiovasc Pharmacol,2004,44(4):473-479.
  • 7Wen TC,Rogido M,Genetta T,et al.Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat biain.Neuroscience Letters.2004;355(3):165-168.
  • 8Tada H,Kagaya Y,Takeda M,etal.Endogenous erythropoietin system in nonhematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.Cardiovasc Res.2006,71(3):408-410.
  • 9Burger D,Xiang F,Hammoud L,etal.Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion.Am J Physiol Heart Circ Physiol,2009,296(1):H84-93.
  • 10Shan X,Xu X,Cao B,et al.Transcription factor GATA-4 is involved in erythropoietin-induced cardioprotection against myocardial ischemia/reperfusion injury.Int J Cardiol,2009,134(3):384-392.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部